Back to Browse Categories
Related journals you may be interested in:
Recent articles:
- 10 records -
CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils
Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ
Journal of Hepatocellular Carcinoma 2024, 11:787-800
Published Date: 8 May 2024
Should an Incidental Meckel Diverticulum Be Resected? A Systematic Review
Yagnik VD, Garg P, Dawka S
Clinical and Experimental Gastroenterology 2024, 17:147-155
Published Date: 7 May 2024
Acute Necrotizing Pancreatitis Complicated with Paroxysmal Nocturnal Haemoglobinuria: A Case Report
Xiao M, Di Y, An Y, Cui Y
Clinical and Experimental Gastroenterology 2024, 17:141-145
Published Date: 29 April 2024
Jejunal Ectopic Pancreatic Tissue Rest as Lead Point in Patients with Intussusception: A Rare Case Report and Review of Literature
Sefefe WM, Tesfaw DB, Tebikew AD, Ayenew AS, Dencha BA, Abebe TA
Clinical and Experimental Gastroenterology 2024, 17:135-139
Published Date: 29 April 2024
A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors
Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S
Journal of Hepatocellular Carcinoma 2024, 11:775-786
Published Date: 26 April 2024
Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
Hu Z, Zhou H
Journal of Hepatocellular Carcinoma 2024, 11:767-774
Published Date: 24 April 2024
A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation
Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2024, 11:747-766
Published Date: 23 April 2024
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
Bu Y, Wen J, Wang F, Dong S, He L, Li Y, Liang J, Zhang H
Hepatic Medicine: Evidence and Research 2024, 16:31-36
Published Date: 20 April 2024
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Imperial R, Mosalem O, Majeed U, Tran NH, Borad MJ, Babiker H
Clinical and Experimental Gastroenterology 2024, 17:121-134
Published Date: 18 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024